Recent reports revealed aberrant up-regulation of TRAP1 in pancreas, colon, lung, prostate and colorectal cancers [18-21], whereas significant loss of TRAP1 expression was also observed in non-Hodgkin lymphomas and pancreatic neuroendocrine tumors [22]. This evidence concerns the gene TRAP1 and colorectal cancer.